Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Cox

Showing results (51-60 of 235) with videos related to

Pageof 24
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Clinical Chemistry|November 22, 2012
Very low PSA concentrations and deletions of the KLK3 geneSantiago Rodriguez, Osama A Al-Ghamdi, Kimberley Burrows, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2010
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancerSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
International Journal of Molecular Epidemiology and Genetics|December 27, 2011
The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?Simon M Collin, Chris Metcalfe, Tom M Palmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic reviewLina Chen, George Davey Smith, David M Evans, et al.
Cancer Research|March 26, 2009
A breast cancer risk haplotype in the caspase-8 geneNeil Duncan Shephard, Ryan Abo, Sushila Harkisandas Rigas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysisSimon M Collin, Chris Metcalfe, Luisa Zuccolo, et al.
Breast Cancer Research and Treatment|September 25, 2007
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter studyBernd Frank, Sushila H Rigas, Justo Lorenzo Bermejo, et al.
Cancer Research|January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk LocusNicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Pageof 24

Showing results (51-60 of 235) with videos related to

Sort By:
Pageof 24
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Clinical Chemistry|November 22, 2012
Very low PSA concentrations and deletions of the KLK3 geneSantiago Rodriguez, Osama A Al-Ghamdi, Kimberley Burrows, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2010
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancerSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
International Journal of Molecular Epidemiology and Genetics|December 27, 2011
The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?Simon M Collin, Chris Metcalfe, Tom M Palmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic reviewLina Chen, George Davey Smith, David M Evans, et al.
Cancer Research|March 26, 2009
A breast cancer risk haplotype in the caspase-8 geneNeil Duncan Shephard, Ryan Abo, Sushila Harkisandas Rigas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysisSimon M Collin, Chris Metcalfe, Luisa Zuccolo, et al.
Breast Cancer Research and Treatment|September 25, 2007
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter studyBernd Frank, Sushila H Rigas, Justo Lorenzo Bermejo, et al.
Cancer Research|January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk LocusNicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Pageof 24